PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report) traded down 1.1% on Wednesday . The stock traded as low as $1.67 and last traded at $1.76. 3,904 shares changed hands during trading, a decline of 56% from the average session volume of 8,831 shares. The stock had previously closed at $1.78.
PharmaCyte Biotech Trading Down 1.1 %
The company has a fifty day simple moving average of $1.65 and a 200-day simple moving average of $1.69.
PharmaCyte Biotech Company Profile
PharmaCyte Biotech, Inc is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
Featured Articles
- Five stocks we like better than PharmaCyte Biotech
- How to Buy Cheap Stocks Step by Step
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- Insider Buying Explained: What Investors Need to Know
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Growth Stocks: What They Are, Examples and How to Invest
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
